Tysabri is a type of disease modifying drug used in the treatment of certain forms of multiple sclerosis (MS). This medication works by preventing leukocytes from crossing the blood-brain barrier into the nervous system where they may exacerbate MS lesions. Tysabri is provided in concentrate form (300mg in 15 ml) for infusion.
| Brand | TYSABRI® |
|---|---|
| Manufacturer | Biogen Idec |
| Active Substances | NATALIZUMAB |
| Strength | 20 mg/ml |
| Pack Size | 1 x 15ml Vial |
